Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Weight Loss Drugs Market Growth in 2025?

The market size of weight loss medications has experienced a significant expansion in the recent past. The market is projected to increase from $2.87 billion in 2024 to $4.23 billion in 2025, evidencing a compound annual growth rate (CAGR) of 47.6%. The escalation during the former period is linked to factors such as accelerated obesity rates, alterations in lifestyle, heightened awareness and education, timely detection of health issues, and an upward trend in healthcare spending.

What Is the Forecast for the Weight Loss Drugs Market Size Through 2029?

It is anticipated that the market size for weight loss drugs will witness a tremendous rise in the coming years. The market is projected to reach $17.08 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 41.7%. The driving factors for this growth during the forecast period are an aging population, the influence of social media, current fitness and wellness trends, societal beauty standards, and investments in the pharmaceutical industry. Modernization in technology, attention towards non-prescription solutions, customized medication, combined treatments, product innovation, and post-market scrutiny are the major trends expected to prevail during the forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp

What are the Key Market Players in Weight Loss Drugs Market and How They’re Evolving?

Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca PLC, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd., Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.

What Are the Primary Growth Drivers in the Weight Loss Drugs Market?

The escalating problem of obesity is predicted to fuel the expansion of the weight loss drugs industry further. The term obesity rate refers to the percentage of individuals within a population having a body mass index (BMI) of 30 or above. Weight loss medications, which are employed in obesity treatments, aid individuals in reducing weight, either by diminishing their appetite, inducing a sense of satiety, or by disrupting the nutrient absorption process. For example, the Centers for Disease Control and Prevention, a US government entity, stated in September 2023, that the adult obesity rates surpassed 35% in 19 states in 2021 and 22 states in 2022. Moreover, the frequency of adult obesity was 35% or higher in 2022. In addition, the World Obesity Federation, a non-profit organization based in the UK, estimated in March 2023 that around 4 billion individuals are likely to be obese by 2035. Consequently, the surging obesity rates are propelling the development of the weight loss drugs industry.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13761&type=smp

What Are the Leading Segments in the Global Weight Loss Drugs Industry?

The weight loss drugs market covered in this report is segmented –

1) By Type: Liquid, Tablets, Capsules

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters

Subsegments:

1) By Liquid: Syrups, Solutions, Suspensions

2) By Tablets: Immediate-Release Tablets, Extended-Release Tablets

3) By Capsules: Hard Capsules, Softgel Capsules

What Are the Key Market Trends in the Weight Loss Drugs Industry?

Leading businesses in the weight loss drug market are concentrating on creating novel products like Zepbound (tirzepatide) injection to accommodate patients’ needs more effectively. Zepbound, a product that is injected once a week, functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. In November 2023, Eli Lilly and Company, a pharmaceutical company rooted in the US, obtained FDA clearance for Zepbound (tirzepatide injection) to cater to chronic weight management in adults who are overweight or obese, with at least one weight-related health issue. With it being the singular FDA-approved obesity remedy that stimulates both GIP and GLP-1 receptors, Zepbound possesses the potential to be a lucrative product in the market.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report

What Is the Regional Outlook for the Weight Loss Drugs Market?

North America was the largest region in the Weight Loss Drugs market in 2024. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13761

This Report Delivers Insight On:

1. How big is the weight loss drugs market, and how is it changing globally?

2. Who are the major companies in the weight loss drugs market, and how are they performing?

3. What are the key opportunities and risks in the weight loss drugs market right now?

4. Which products or customer segments are growing the most in the weight loss drugs market?

5. What factors are helping or slowing down the growth of the weight loss drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model